tiprankstipranks
Benitec Biopharma (BNTC)
:BNTC
US Market
Holding BNTC?
Track your performance easily

Benitec Biopharma (BNTC) Financial Statements

255 Followers

Benitec Biopharma Financial Overview

Benitec Biopharma's market cap is currently ―. The company's EPS TTM is $-5.278; its P/E ratio is ―; Benitec Biopharma is scheduled to report earnings on February 17, 2025, and the estimated EPS forecast is $-0.78. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit---$ -1.00K$ 106.00K
EBIT$ -5.06M$ -4.51M$ -4.28M$ -6.79M$ -5.95M
EBITDA$ -4.97M$ -4.42M$ -4.19M$ -6.71M$ -5.87M
Net Income Common Stockholders$ -5.06M$ -5.34M$ -4.28M$ -6.80M$ -5.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 67.80M$ ―$ ―$ 20.40M$ 25.90M
Total Assets$ 68.77M$ 52.21M$ 15.00M$ 21.35M$ 27.05M
Total Debt$ ―$ ―$ 354.00K$ 423.00K$ 491.00K
Net Debt$ ―$ ―$ ―$ -19.98M$ -25.41M
Total Liabilities$ 4.59M$ 4.96M$ 3.50M$ 5.88M$ 4.75M
Stockholders Equity$ 64.18M$ 47.25M$ 11.50M$ 15.47M$ 22.31M
Cash Flow-
Free Cash Flow$ -4.60M$ -3.30M$ -6.38M$ -5.37M$ -4.58M
Operating Cash Flow$ -4.60M$ -3.30M$ -6.20M$ -5.37M$ -4.58M
Investing Cash Flow--$ -179.00K--
Financing Cash Flow$ 21.66M$ 40.07M-$ 39.00K$ 27.92M
Currency in USD

Benitec Biopharma Earnings and Revenue History

Benitec Biopharma Debt to Assets

Benitec Biopharma Cash Flow

Benitec Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis